Provenienza dei contatti di primo grado di Francois Spertini
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Anergis SA
Anergis SA Pharmaceuticals: GenericHealth Technology Anergis SA develops allergy vaccines. It is a biopharmaceutical company specializing in the discovery and development of novel, proprietary allergy vaccines that target commercially attractive indications and the firm’s vaccines are based on its IP-protected Contiguous Overlapping Peptide technology.The company was founded by Francois Spertini in August 2001 and is headquartered in Epalinges, Switzerland.
11
| Holding Company | Pharmaceuticals: Generic | 11 |
Centre Hospitalier Universitaire Vaudois
Centre Hospitalier Universitaire Vaudois Hospital/Nursing ManagementHealth Services Centre Hospitalier Universitaire Vaudois is a university hospital located in Lausanne, CH. The SwitzerlandUV is also a renowned center of medical education and research, collaborating with the Faculty of Biology and Medicine of the University of Lausanne and the Swiss Federal Institute of Technology in Lausanne (EPFL). It has 16 clinical and medico-technical departments and is known for its academic achievements in healthcare, research, and teaching. The vast campus in the lake region is home to these institutions. The CEO of the Swiss company is Nicolas Demartines.
3
| Private Company | Hospital/Nursing Management | 3 |
Fondation Soins Intensifs & Centre Brûlés Centre Hospitalier
Fondation Soins Intensifs & Centre Brûlés Centre Hospitalier Hospital/Nursing ManagementHealth Services Fondation Soins Intensifs & Centre Brûlés Centre Hospitalier is a medical services provider based in Lausanne, Switzerland. The Swiss company provides medical services and is ultimately controlled by the Government of Switzerland.
1
| Subsidiary | Hospital/Nursing Management | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Francois Spertini tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ROCHE HOLDING AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal General Counsel | |
Les Laboratoires Servier SAS
Les Laboratoires Servier SAS Pharmaceuticals: MajorHealth Technology Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Synexus Compass, Inc.
Synexus Compass, Inc. Medical/Nursing ServicesHealth Services Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Danish Venture Capital & Private Equity Association
Danish Venture Capital & Private Equity Association Investment ManagersFinance The Danish Venture Capital & Private Equity Association is an organization that represents business owners who are members of the association. The private company is based in Copenhagen, Denmark. The Danish company has recently released their annual activity report for the entire ecosystem of active ownership. The report can be downloaded from their website. Additionally, they have listed six specific wishes for political party leaders on their website. and has subsidiaries in Denmark. | Investment Managers | Director/Board Member | |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | Corporate Officer/Principal | |
M&B AS
M&B AS Agricultural Commodities/MillingProcess Industries Part of Taconic Biosciences, Inc., M&B AS breeds laboratory mice and rats for the scientific community. The company is based in Ry, Denmark. M&B was acquired by Taconic Biosciences, Inc. on May 01, 2002. | Agricultural Commodities/Milling | Chief Executive Officer | |
University of California San Diego | College/University | Corporate Officer/Principal | |
University of Colorado Health Sciences Center | College/University | Corporate Officer/Principal | |
University of Pavia | College/University | Doctorate Degree | |
University of Geneva | College/University | Doctorate Degree | |
Swiss Federal Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal | |
University of Lausanne | College/University | Doctorate Degree Corporate Officer/Principal | |
Speedel Pharma AG
Speedel Pharma AG Pharmaceuticals: MajorHealth Technology Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SCT-Spinal Cord Therapeutics GmbH
SCT-Spinal Cord Therapeutics GmbH Miscellaneous Commercial ServicesCommercial Services SCT-Spinal Cord Therapeutics GmbH, a biopharmaceutical company based in Düsseldorf, Germany, is focused on the treatment of traumatic injury to the central nervous system. SCT`s proprietary key technology, the Regeneration Promoting Treatment, is an unique and promising treatment approach aimed at the supression of scar formation. The inhibition of scar formation allows the severed nerves to sprout and/or regenerate which in turn enables the recovery of sensory and motor function. As a first application of the Regeneration Promoting Treatment SCT is focusing on the development of Cordaneurin, a drug for the treatment of acute spinal cord injuries. In pre-clinical studies Cordaneurin has demonstrated its efficacy in the recovery of motor function after spinal cord contusion. | Miscellaneous Commercial Services | Director/Board Member | |
Merck Serono SA
Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Ares-Serono Group
Ares-Serono Group Pharmaceuticals: MajorHealth Technology Ares-Serono Group is a Swiss pharmaceutical company that manufactures and wholesales pharmaceutical products. The private company is based in Geneva, Switzerland. and has subsidiaries in Ecuador. | Pharmaceuticals: Major | Corporate Officer/Principal | |
StemCare A/S
StemCare A/S BiotechnologyHealth Technology StemCare A/S operates as a private stem cell bank. The firm stores stem cells from umbilical cord blood. The company was founded by Sten Verland in 2003 and is headquartered in Gentofte, Denmark. | Biotechnology | Founder | |
DMS IMAGING | Biotechnology | Chief Tech/Sci/R&D Officer | |
OxThera AB
OxThera AB Pharmaceuticals: GenericHealth Technology OxThera AB develops pharmaceutical products for treatment of hyperoxaluria. Its intellectual property includes worldwide patents for compositions and treatment of hyperoxaluria with bacteria and enzymes. The firm?s products in pipeline include Oxabact, for the treatment of primary hyperoxaluria and oxazyme for the prevention of oxalate malabsorption and recurring kidney stones in secondary hyperoxaluria. The company was founded in 2005 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
biolitec Pharma Ltd.
biolitec Pharma Ltd. Medical SpecialtiesHealth Technology biolitec Pharma Ltd. produces and markets a photo technology platform for the treatment of head and neck cancer. Its product Foscan, is a porphyrin photosensitising device used for the treatment of head and neck cancer in patients who cannot be treated with other therapies. The company is headquartered in Dublin, Ireland. | Medical Specialties | General Counsel | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Zymenex Holding A/S
Zymenex Holding A/S BiotechnologyHealth Technology Zymenex Holding A/S engages in the research and development of therapeutics for life threatening diseases. The company is headquartered in Hillerod, Denmark. | Biotechnology | Chairman | |
European Research Council
European Research Council Investment Trusts/Mutual FundsMiscellaneous The European Research Council is an organization that provides grants for research projects. The organization is based in Brussels, Belgium. As a grantee, individuals are required to submit scientific and financial reports for assessment by ERC Scientific Officers. The organization emphasizes the importance of research ethics and compliance with legislation, disciplinary norms, and protection of research subjects. The responsibility for ethics lies with the individuals conducting the research, while the formal accountability lies with the signatory of the Grant Agreement, the Host Institution. | Investment Trusts/Mutual Funds | Treasurer | |
Swissmedic
Swissmedic Miscellaneous Commercial ServicesCommercial Services Swissmedic is the national authorisation and supervisory authority for drugs and medical products. It provides clinical laboratory testing services. The company is headquartered in Bern, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
Dictagene | Founder | ||
Skovlyst Production A/S
Skovlyst Production A/S Beverages: AlcoholicConsumer Non-Durables Skovlyst Production A/S operates a brewery restaurant. It serves a hand-brewed beer from elderflower, birch sap, beech twigs, woodruff, and nettles. The firm also offers a combined picnic with beer tasting. The company was founded by Casper Mikkel Møller on February 21, 2007 and is headquartered in Birkerød, Denmark. | Beverages: Alcoholic | Director/Board Member | |
Rigontec GmbH
Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Onward Medical SA
Onward Medical SA BiotechnologyHealth Technology ONWARD Inc develops medical devices. It also provides stimulation system to rehabilitate individuals with spinal cord injury. The company was founded by Jocelyn Bloch, Sjaak Deckers, Grégoire Courtine, and Vincent Delattre in December 2014 and is headquartered in Lausanne, Switzerland. | Biotechnology | Founder | |
RELIEF THERAPEUTICS HOLDING SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Verland Holding ApS | Corporate Officer/Principal | ||
Tera Holding A/S
Tera Holding A/S Real Estate DevelopmentFinance Tera Holding A/S provides commercial property rental services. The private company is based in Karlslunde, Denmark. | Real Estate Development | Director/Board Member | |
Vetverland ApS | Chief Executive Officer | ||
STipe Therapeutics ApS
STipe Therapeutics ApS Pharmaceuticals: MajorHealth Technology STipe Therapeutics ApS operates as a biotechnology company. It specializes in the immune-oncology field, pioneer therapies using a novel aspect of the stimulator of interferon genes (STING) Pathway to target cancer. The company was founded in 2018 and is headquartered in Denmark. | Pharmaceuticals: Major | Director/Board Member | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Tollys
Tollys Hospital/Nursing ManagementHealth Services Tollys is a French company that specializes in developing clinical-grade TLR3 ligands for cancer immunotherapy. The company is based in Lyon, France and was founded by Dominique Rigal. The company's co-founders discovered that TLR3 agonists have the potential to induce direct and immunogenic tumor cell death while sparing normal cells. Tollys has filled a patent for a new family of TLR3 ligands and confirmed freedom to operate. The CEO is Vincent Charlon. | Hospital/Nursing Management | Director/Board Member Chief Executive Officer | |
ONWARD MEDICAL N.V. | Miscellaneous Commercial Services | Founder | |
Dellmed Consulting | Founder | ||
Vaximm AG
Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Swiss Society of Nephrology | Corporate Officer/Principal | ||
European Society of Hypertension | Treasurer | ||
Swiss Society of Hypertension | Corporate Officer/Principal | ||
Genobiotix ApS
Genobiotix ApS BiotechnologyHealth Technology Genobiotix ApS engages in research and experimental development on biotechnology. It develops and commercializes methods for producing new antibiotics. The company was founded by Kenn Axø Gerdes and Anders Løbner-Olesen on January 23, 2004 and is headquartered in Bagsvaerd, Denmark. | Biotechnology | Chief Executive Officer |
Statistiche
Distribuzione geografica
Svizzera | 20 |
Danimarca | 13 |
Stati Uniti | 6 |
Francia | 6 |
Germania | 4 |
Settori
Health Technology | 23 |
Consumer Services | 8 |
Commercial Services | 6 |
Health Services | 3 |
Finance | 3 |
Posizioni
Director/Board Member | 44 |
Corporate Officer/Principal | 36 |
Chairman | 12 |
Chief Executive Officer | 11 |
Doctorate Degree | 9 |
Contatti più connessi
Insiders | |
---|---|
Sten Verland | 28 |
Klaus Schollmeier | 17 |
Markus Hosang | 15 |
Michel Burnier | 13 |
Gilles Della Corte | 10 |
Dino Dina | 8 |
Zoltán Czigler | 7 |
Vincent Charlon | 6 |
Grégoire Courtine | 6 |
Sylvain Fleury | 4 |
Christophe Reymond | 4 |
Vanya Beltrami | 4 |
Gerard Farmer | 3 |
Alexander Kettner | 1 |
Nicolas Demartines | 1 |
- Borsa valori
- Insiders
- Francois Spertini
- Connessioni Società